Pterin derivatives – aminopterin and methotrexate – are competitive inhibitors of dihydrofolate reductase. As a result, they suppress the regeneration of tetrahydrofolic acid from dihydrofolate. These medicines lead to the inhibition of intermolecular transport of one-carbon groups. In the process, the biosynthesis of the following polymer is suppressed: